News

Published on 24 Sep 2024 on Insider Monkey · via Yahoo Finance

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?


Article preview image

We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a...

NASDAQ.FOLD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Why Amicus Therapeutics, Inc. (FOLD) is the Most Oversold Pharma Stock to Buy...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In th...

Insider Monkey · via Yahoo Finance 23 Feb 2025

Amicus Therapeutics CEO Campbell Bradley sells $4,000 in stock By Investing.com

Amicus Therapeutics CEO Campbell Bradley sells $4,000 in stock

Investing.com 22 Feb 2025

FOLD's Q4 Earnings Miss, Higher Product Sales Drive Revenue Growth

Some other top-ranked stocks in the biotech sector are Harmony Biosciences Holdings, Inc. HRMY an...

Zacks · via Yahoo Finance 21 Feb 2025

Amicus Therapeutics Inc (FOLD) Q4 2024 Earnings Call Highlights: Strong Revenue...

Total Revenue: $528 million for the full year 2024, a 32% increase year over year. Galafold Reven...

GuruFocus.com · via Yahoo Finance 20 Feb 2025

Amicus Therapeutics, Inc. (FOLD): The Biotech Stock with Biggest Upside...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 17 Jan 2025

Amicus Therapeutics CEO Campbell sells $98,800 in stock By Investing.com

On November 6, Campbell sold 7,901 shares of common stock at an average price of $12.5048, totali...

Investing.com 8 Nov 2024

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue...

Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Earnings call: Amicus Therapeutics reports robust Q3 growth, raises guidance By...

Amicus Therapeutics (NASDAQ: NASDAQ:FOLD) has reported a significant increase in revenue for the...

Investing.com 6 Nov 2024

Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue...

Total Revenue: $127 million, a 34% increase year-over-year, or 36% on a constant currency basis....

GuruFocus.com · via Yahoo Finance 11 Oct 2024

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?

We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have ...

Insider Monkey · via Yahoo Finance 24 Sep 2024